ENTO
Entero Therapeutics
ENTO
ENTO
12 hedge funds and large institutions have $601K invested in Entero Therapeutics in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less capital invested
Capital invested by funds: $1.05M → $601K (-$450K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$39K | |
| 2 | +$13.7K | |
| 3 | +$12K | |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
+$11K |
Top Sellers
| 1 | -$118K | |
| 2 | -$82K | |
| 3 | -$80.1K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$8K |